Reducing the risks when using benzodiazepines to treat insomnia: A public health approach.
Level V
Where this comes from
- Record sourced from PubMed, PMID 38692699.
- Also identified by DOI 10.3949/ccjm.91a.23061.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Benzodiazepines are widely used but can cause considerable harm, including sedation, addiction, falls, fractures, and cognitive impairment, especially with long-term use and in elderly patients. The authors propose a public health approach to reduce the potential for harm when using benzodiazepines to treat insomnia. Primary prevention involves judicious patient selection and patient education. Secondary prevention requires keeping the duration of use as short as possible according to guidelines. Tertiary prevention, for patients who have been taking a benzodiazepine for a long time, uses shared decision-making to introduce a gradual and carefully monitored taper.
Medical subject headings
- Sleep Initiation and Maintenance Disorders
- Benzodiazepines